SITAGLIPTIN OR GLIBENCLAMIDE IN ADDITION TO METFORMIN+PIOGLITAZONE?

Authors' Reports

Giuseppe Derosa
describes for SIIC the most significant aspects of his article
describe para SIIC los aspectos relevantes de su artículo

Sitagliptin vs glibenclamide
SITAGLIPTIN OR GLIBENCLAMIDE IN ADDITION TO METFORMIN+PIOGLITAZONE?

When metformin and pioglitazone combination is not enough to maintain an adequate glycemic control, sitagliptin should be preferred to glibenclamide as addition to the already ongoing therapy, for its better protection of beta-cell secretion, and its neutral effect on body weight.

The article was published by
El artículo fue publicado por

Diabetic Medicine
Volume / Volumen: 30
Number / Número: 7
First and last pages / Páginas inicial-final: 846-854
Year / Año: 2013
Month / Mes: july

This journal, which is covered by SIIC Data Bases,
is part of the bibliographic collections of the Biblioteca Biomédica (BB) SIIC.
Esta revista, clasificada por SIIC Data Bases,
integra el acervo bibliográfico de la Biblioteca Biomédica (BB) SIIC.

Principal institution where the research took place
Institución principal de la investigación
Department of Internal Medicine and Therapeutics, University of Pavia, PAVIA, Italy, Pavia, Italy, Italy

Authors' Report
Crónica del Autor
Print

Bibliographic references
Referencias bibliográficas

Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, et al.; American Diabetes Association; European Association for Study of Diabetes. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 32(1):193-203, 2009.
Nauck MA, Meininger G, Sheng D, Terranella L, Stein PP; Sitagliptin Study 024 Group. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial. Diabetes Obes Metab 9(2):194-205, 2007.
Weir GC, Leahy JL. Pathogenesis of non-insulin-dependent (type II) diabetes mellitus. In Joslin's diabetes mellitus. 13th edition. CR Kahn and GE Weir (eds.) Lea & Febiger. Philadelphia, PA; 1994. Pp. 240-264.
Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104(6):787-794, 1999.
Williams-Herman D, Xu L, Teng R, Golm GT, Johnson J, Davies MJ, et al. Effect of initial combination therapy with sitagliptin and metformin on beta-cell function in patients with type 2 diabetes. Diabetes Obes Metab 14(1):67-76, 2012.

Other articles written by the author Giuseppe Derosa
Otros artículos de Giuseppe Derosa

Derosa G, Maffioli P. Peroxisome proliferator-activated receptor-γ (Ppar-γ) agonists on glycemic control, lipid profile and cardiovascular risk. Curr Mol Pharmacol 2012; 5(2): 272-281.

Derosa G. Pioglitazone is a valid alternative to rosiglitazone. Am J Cardiovasc Drugs 2011; 11(6): 357-362.

Derosa G. Efficacy and tolerability of pioglitazone in patients with type 2 diabetes mellitus: comparison with other oral antihyperglycaemic agents. Drugs 2010; 70(15): 1945-1961.

Derosa G, Tinelli C, Maffioli P. Effects of pioglitazone and rosiglitazone combined with metformin on body weight in people with diabetes. Diabetes Obes Metab 2009; 11(12): 1091-1099.

Derosa G, Salvadeo SA, D'Angelo A, Ferrari I, Mereu R, Palumbo I, Maffioli P, Randazzo S, Cicero AF. Metabolic effect of repaglinide or acarbose when added to a double oral antidiabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trial. Curr Med Res Opin 2009; 25(3): 607-615.

Derosa G, Ragonesi PD, Carbone A, Fogari E, Bianchi L, Bonaventura A, Romano D, Cicero AF, Maffioli P. Vildagliptin added to metformin on β-cell function after an euglycemic hyperinsulinemic and hyperglycemic clamp in type 2 diabetic patients. Diabetes Technol Ther 2012; 14(6):475-484.

Derosa G, Franzetti IG, Querci F, Carbone A, Ciccarelli L, Piccinni MN, Fogari E, Maffioli P. Exenatide plus metformin compared to metformin alone on β-cell function in patients with type 2 diabetes. Diabet Med; 29(12): 1515-1523.

Derosa G, Maffioli P, Salvadeo SA, Ferrari I, Gravina A, Mereu R, Palumbo I, D'Angelo A, Cicero AF. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study. Metabolism 2009; 58(8): 1059-1066.

Derosa G, D'Angelo A, Ragonesi PD, Ciccarelli L, Piccinni MN, Pricolo F, Salvadeo SA, Montagna L, Gravina A, Ferrari I, Paniga S, Cicero AF. Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with metformin. Intern Med J 2007; 37(2): 79-86.

Derosa G, Cicero AF, Fogari E, D'Angelo A, Bianchi L, Maffioli P. Pioglitazone compared to glibenclamide on lipid profile and inflammation markers in type 2 diabetic patients during an oral fat load. Horm Metab Res 2011; 43(7): 505-512.

SIIC System of Assisted Editing (SSEA)
/ Sistema SIIC de Edición Asistida (SSEA)



The authors' report was accepted on La crónica del autor fue aprobada el 2021, march 9	Published in siicsalud Publicado en siicsalud 2021, june 7

The article is strictly related to the following sections of siicsalud
El artículo se relaciona estrictamente con las siguientes secciones de siicsalud

Diabetology
/ Diabetología

Internal Medicine
/ Medicina Interna

and secondarily related to the following sections
y secundariamente con las siguientes secciones

Endocrinology and Metabolism
Endocrinología y Metabolismo

Pharmacology
Farmacología

Information about the full text
Acerca del trabajo completo

A Comparison Between Sitagliptin or Glibenclamide in Addition to Metformin + Pioglitazone on Glycaemic Control and Beta-Cell Function: The Triple Oral Therapy

Author / Autor
Giuseppe Derosa¹, Arrigo Cicero², Ivano Franzetti³, Fabrizio Querci⁴, Anna Carbone⁵, Mario Piccinni⁶, Angela D'angelo⁷, Elena Fogari⁸, Pamela Maffioli⁹

9 Md, Department Of Internal Medicine And Therapeutics, University Of Pavia, Pavia, Italy

Access to the original source
Diabetic Medicine

Article URL: / URL del artículo:
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1464-5491
URL of Abstract: / URL del abstract:
http://onlinelibrary.wiley.com/doi/10.1111/dme.12158/abstract
URL of Abstract page in Medline: / URL del abstract en Medline:
http://www.ncbi.nlm.nih.gov/pubmed/23413771
URL of Abstract page in Scopus: / URL del abstract en Scopus:
http://2-s2.0-84879592855
siic DB: / siic DB:
http://www.siicsalud.com/main/distriprinrel.php

ua32218

Acerca de SIIC

Authors' Reports

Acceso para suscriptores